These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22932002)

  • 41. Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study.
    Chen VC; Lu ML; Yang YH; Weng JC; Chang CC
    J Affect Disord; 2019 Jun; 253():147-153. PubMed ID: 31035215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of low accelerating dose regimen of interferon/ribavirin antiviral therapy in patients with hepatitis C virus recurrence after liver transplantation.
    Su H; Liu Z; Sun Y; Li H; Zhou S; Zhou X; Gao Y; Tang R; Zhang D; Zhang M
    Ann Transplant; 2015 May; 20():263-8. PubMed ID: 25975740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The possible intraspousal transmission of HCV in terms of lichen planus.
    Nagao Y; Tomonari R; Kage M; Komai K; Tsubone K; Kamura T; Sata M
    Int J Mol Med; 2002 Nov; 10(5):569-73. PubMed ID: 12373293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study.
    Carrozzo M; Gandolfo S; Carbone M; Colombatto P; Broccoletti R; Garzino-Demo P; Ghisetti V
    J Oral Pathol Med; 1996 Nov; 25(10):527-33. PubMed ID: 8986963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan.
    Nagao Y; Sata M; Tanikawa K; Itoh K; Kameyama T
    Eur J Clin Invest; 1995 Dec; 25(12):910-4. PubMed ID: 8719930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
    Hagihara H; Nouso K; Kobayashi Y; Iwasaki Y; Nakamura S; Kuwaki K; Toshimori J; Miyatake H; Ohnishi H; Shiraha H; Yamamoto K
    Int J Clin Oncol; 2011 Jun; 16(3):210-20. PubMed ID: 21152943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients.
    Kuwana K; Ichida T; Kamimura T; Ohkoshi S; Ogata N; Harada T; Endoh K; Asakura H
    J Gastroenterol Hepatol; 1997 Feb; 12(2):149-55. PubMed ID: 9083916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.
    Akuta N; Suzuki F; Tsubota A; Suzuki Y; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Hepatol; 2002 Dec; 37(6):831-6. PubMed ID: 12445425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection.
    Lodi G; Olsen I; Piattelli A; D'Amico E; Artese L; Porter SR
    J Oral Pathol Med; 1997 Jan; 26(1):36-9. PubMed ID: 9021550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital.
    Okushin K; Suzuki R; Tsutsumi T; Okamoto K; Ikeuchi K; Kado A; Minatsuki C; Minami-Kobayashi Y; Satoh N; Ikeda M; Harada S; Enooku K; Fujinaga H; Yotsuyanagi H; Koike K; Moriya K
    BMC Infect Dis; 2021 Apr; 21(1):399. PubMed ID: 33931015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy.
    D'Ambrosio R; Aghemo A; Rumi MG; Primignani M; Dell'Era A; Lampertico P; Donato MF; De Nicola S; Prati GM; de Franchis R; Colombo M
    Antivir Ther; 2011; 16(5):677-84. PubMed ID: 21817189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective study of short-term peginterferon-alpha-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy.
    Jeong S; Kawakami Y; Kitamoto M; Ishihara H; Tsuji K; Aimitsu S; Kawakami H; Uka K; Takaki S; Kodama H; Waki K; Imamura M; Aikata H; Takahashi S; Chayama K
    J Gastroenterol Hepatol; 2008 Apr; 23(4):541-5. PubMed ID: 18397484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study.
    Nagao Y; Kawaguchi T; Ide T; Sata M
    Virol J; 2012 Nov; 9():282. PubMed ID: 23173649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term pegylated interferon monotherapy following 72 weeks of pegylated interferon and ribavirin in hepatitis C virus genotype-1-infected slow responders.
    Watanabe S; Kobayashi Y; Kawata K; Noritake H; Chida T; Nagasawa M; Kageyama F; Kawamura K; Sasada Y; Suda T
    Intern Med; 2015; 54(3):273-9. PubMed ID: 25748735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients.
    Merchante N; Rodríguez-Arrondo F; Revollo B; Merino E; Ibarra S; Galindo MJ; Montero M; García-Deltoro M; Rivero-Juárez A; Téllez F; Delgado-Fernández M; Ríos-Villegas MJ; García MA; Vera-Méndez FJ; Ojeda-Burgos G; López-Ruz MA; Metola L; Omar M; Alemán-Valls MR; Aguirrebengoa K; Portu J; Raffo M; Macías J; Pineda JA;
    AIDS; 2018 Jul; 32(11):1423-1430. PubMed ID: 29596108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine gene polymorphisms in hepatitis C virus-related oral lichen planus.
    Carrozzo M; Dametto E; Fasano ME; Arduino P; Bertolusso G; Uboldi de Capei F; Rendine S; Amoroso A
    Exp Dermatol; 2007 Sep; 16(9):730-6. PubMed ID: 17697145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management strategies using pharmacogenomics in patients with severe HCV-1b infection: a decision analysis.
    Moriguchi H; Uemura T; Kobayashi M; Chung RT; Sato C
    Hepatology; 2002 Jul; 36(1):177-85. PubMed ID: 12085363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of double-filtration plasmapheresis plus interferon treatment in nonresponders to pegylated interferon plus ribavirin combination therapy.
    Sugimoto K; Kim SR; El-Shamy A; Imoto S; Fujioka H; Kim KI; Tanaka Y; Yano Y; Kim SK; Hasegawa Y; Fujinami A; Ohta M; Hatae T; Hotta H; Hayashi Y; Kudo M
    Dig Dis; 2013; 31(5-6):434-9. PubMed ID: 24281017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis C.
    Noritake H; Kobayashi Y; Ooba Y; Matsunaga E; Ohta K; Shimoyama S; Yamazaki S; Chida T; Kawata K; Sakaguchi T; Suda T
    J Interferon Cytokine Res; 2015 Dec; 35(12):956-62. PubMed ID: 26308703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.